HU905221D0 - Process for producing new 6-methyl-19-nor-steroids, pharmaceutical preparatives containing them and transformation them into 19-nor-pregna-dienes substituted in 17-alpha position - Google Patents

Process for producing new 6-methyl-19-nor-steroids, pharmaceutical preparatives containing them and transformation them into 19-nor-pregna-dienes substituted in 17-alpha position

Info

Publication number
HU905221D0
HU905221D0 HU905221A HU522190A HU905221D0 HU 905221 D0 HU905221 D0 HU 905221D0 HU 905221 A HU905221 A HU 905221A HU 522190 A HU522190 A HU 522190A HU 905221 D0 HU905221 D0 HU 905221D0
Authority
HU
Hungary
Prior art keywords
pregna
steroids
transformation
methyl
alpha position
Prior art date
Application number
HU905221A
Other languages
Hungarian (hu)
Other versions
HUT59154A (en
HU209590B (en
Inventor
Claude Tchernatinsky
Nejib Mohamed Nasraoui
Alain Piasco
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of HU905221D0 publication Critical patent/HU905221D0/en
Publication of HUT59154A publication Critical patent/HUT59154A/en
Publication of HU209590B publication Critical patent/HU209590B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0055Estrane derivatives not substituted in position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
HU905221A 1989-05-24 1990-05-23 Process for the production of 6-methyl-19-nor-steroids and of pharmaceutical compositions comprising them HU209590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906790A FR2647452A1 (en) 1989-05-24 1989-05-24 NEW 19-NOR 6-METHYL STEROIDS PROCESSES FOR OBTAINING THEM, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR CONVERSION IN 19-NOR PREGNADIAN 17-SUBSTITUTED

Publications (3)

Publication Number Publication Date
HU905221D0 true HU905221D0 (en) 1991-07-29
HUT59154A HUT59154A (en) 1992-04-28
HU209590B HU209590B (en) 1994-08-29

Family

ID=9381962

Family Applications (1)

Application Number Title Priority Date Filing Date
HU905221A HU209590B (en) 1989-05-24 1990-05-23 Process for the production of 6-methyl-19-nor-steroids and of pharmaceutical compositions comprising them

Country Status (12)

Country Link
EP (1) EP0431107A1 (en)
JP (1) JPH04503362A (en)
KR (1) KR920701231A (en)
AU (1) AU643218B2 (en)
FI (1) FI910351A0 (en)
FR (1) FR2647452A1 (en)
GR (1) GR900100394A (en)
HU (1) HU209590B (en)
MA (1) MA21851A1 (en)
PT (1) PT94134A (en)
TN (1) TNSN90066A1 (en)
WO (1) WO1990015067A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679236B1 (en) * 1991-07-18 1997-01-24 Theramex NOVEL STEROUIDES SUBSTITUTED IN POSITION 6, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
AU2002357610A1 (en) * 2001-12-19 2003-06-30 Chugai Seiyaku Kabushiki Kaisha Androstane derivative having substituent in 7- and 17-positions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE641817A (en) * 1963-02-28
JPS504657B1 (en) * 1968-07-30 1975-02-22
DE3204281C1 (en) * 1982-02-05 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Process for the preparation of 6-methyl-delta? -3-ketosteroids
DE3346204A1 (en) * 1983-12-21 1985-07-11 Council Of Scientific And Industrial Research, New Delhi Process for the preparation of 17 beta -[(1-oxoheptyl)oxy]-19-norpregn-4-en-20-yn-3-one (norethisterone oenanthate) and esters thereof and pharmaceutical compositions containing these
FR2576025B1 (en) * 1985-01-14 1987-01-23 Roussel Uclaf NOVEL SUBSTITUTED STEROIDS IN POSITION 10, THEIR PROCESS AND THE PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CN1008820B (en) * 1985-05-10 1990-07-18 施林工业产权保护股份公司 Process for the production of 17 alpha-ethynyl-17beta-hydroxy-18-methyl-4, 15-estradien-3-one

Also Published As

Publication number Publication date
WO1990015067A2 (en) 1990-12-13
EP0431107A1 (en) 1991-06-12
FR2647452A1 (en) 1990-11-30
AU643218B2 (en) 1993-11-11
FI910351A0 (en) 1991-01-23
MA21851A1 (en) 1990-12-31
KR920701231A (en) 1992-08-11
HUT59154A (en) 1992-04-28
JPH04503362A (en) 1992-06-18
WO1990015067A3 (en) 1991-01-24
PT94134A (en) 1991-01-08
TNSN90066A1 (en) 1991-03-05
GR900100394A (en) 1991-10-10
HU209590B (en) 1994-08-29
AU5742690A (en) 1991-01-07

Similar Documents

Publication Publication Date Title
HUT53362A (en) Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same
HUT54491A (en) Quickly soluble pharmaceutical unit dosage and process for producing same
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
HUT58326A (en) Process for producing pipeidine derivatives and pharmaceutical compositions containing them
HU903281D0 (en) Process for producing 2-hydroxy-n-propyl-amines and containing them pharmaceutical preparatives
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
HU903486D0 (en) Process for producing halogene-substituted diphenyl-sulfides and pharmaceutical preparatives containing these compounds
HUT56078A (en) Process for producing piridazine derivatives and pharmaceutical compositions containing them
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
HU913656D0 (en) 9-alpha-hydroxi-11-beta-bridged steroides, method for producing them and pharmaceutical preparatives containing said compounds
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
HUT46644A (en) Process for producing propylophenone derivatives and pharmaceutical compositions comprising the same
HUT53802A (en) Process for producing pharmaceutical preparations containing piperidino-alkanole-derivatives
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same
HU904661D0 (en) 14,17-alpha-etheno- and -ethano-esthatrienes and process for producing these compounds as well as pharmaceutical preparatives containing them
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
HUT50472A (en) Process for producing new condensed diazepinones and pharmaceutical compositions comprising the same
HUT54165A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising same
HU905221D0 (en) Process for producing new 6-methyl-19-nor-steroids, pharmaceutical preparatives containing them and transformation them into 19-nor-pregna-dienes substituted in 17-alpha position
HU907129D0 (en) Process for producing pharmaceutical preparatives
HUT49351A (en) Process for producing new condensed diazepinones and pharmaceutical compositions comprising same
HU202557B (en) Process for producing sialinic acid-octapeptide and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee